Posted on 5月 16, 20235/16/23
Critical Success Factors for Launching Products with Fast Track, PRIME, or ILAP Designation
Posted on 5月 1, 20235/1/23
2023 Outlook Of China Healthcare Industry: Remaining Pragmatic While Moving Up The Value Chain
Posted on 4月 5, 20234/5/23
Navigating Routes to Commercial Excellence in Cell and Gene Therapy
Posted on 4月 4, 20234/4/23
Achieving Digital Enlightenment in 2023 and Beyond
Posted on 2月 21, 20232/21/23
Critical Success Factors for Launching Products with Orphan Drug Designation
Posted on 1月 30, 20231/30/23
Bending the “Commercialization Curve” in Large Pharma
Posted on 1月 18, 20231/18/23
Account Engagement Excellence: How Advanced Analytics Can Enable Next-Generation Account Segmentation
Posted on 11月 22, 202211/22/22
Ready or Not, Biosimilar Adalimumab Brings the Heat in 2023
Posted on 11月 16, 202211/16/22